Harvard Bioscience | 10-Q: Quarterly report
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
07:18 AM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
Harvard Bioscience Sees FY24 Revenues Approximately Flat Versus 2023 >HBIO
Harvard Bioscience Sees FY24 Revenues Approximately Flat Versus 2023 >HBIO
Harvard Bioscience 1Q Adj EPS 2c >HBIO
Harvard Bioscience 1Q Adj EPS 2c >HBIO
Press Release: Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) wil
Harvard Bioscience Announces Labor Force Reduction
Harvard Bioscience Expects Overall Run Rate Savings Of ~$4M Beginning In Q2 2024; Expects Q2 Restructuring-Related Charges Of ~$0.5M
Harvard Bioscience Expects Overall Run Rate Savings Of ~$4M Beginning In Q2 2024; Expects Q2 Restructuring-Related Charges Of ~$0.5M
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing i
Harvard Bioscience Sets Incentive Plan for Top Executives
Investing in Harvard Bioscience (NASDAQ:HBIO) a Year Ago Would Have Delivered You a 25% Gain
Sidoti Events, LLC's Virtual March Small-Cap Conference
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at
Is There An Opportunity With Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 34% Undervaluation?
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 EPS $0.04
07:04 AM EST, 03/07/2024 (MT Newswires) -- Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 EPS $0.04
Harvard Bioscience Non-GAAP EPS of $0.04 Misses by $0.01, Revenue of $28.2M Misses by $0.4M
Harvard Bioscience Sees Flat to Modest Revenue Growth for FY24>HBIO
Harvard Bioscience Sees Flat to Modest Revenue Growth for FY24>HBIO
Harvard Bioscience 4Q Loss $1.8M >HBIO
Harvard Bioscience 4Q Loss $1.8M >HBIO
Harvard Bioscience 4Q Rev $28.2M >HBIO
Harvard Bioscience 4Q Rev $28.2M >HBIO
Press Release: Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results -- Q4 Revenues of $28.2 million -- Q4 Gross Margin of 58.0% (230 bps year-over-year improvement) -- Q4 operating income of
No Data